- Home
- IVDA vs BBLG Comparison
IVDA vs BBLG Comparison
Compare IVDA & BBLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IVDA | BBLG |
|---|---|---|
| Founded | 2003 | 2004 |
| Country | United States | United States |
| Employees | 32 | 2 |
| Industry | Computer Software: Prepackaged Software | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9M | 2.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | IVDA | BBLG |
|---|---|---|
| Price | $0.33 | $1.32 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 412.6K | 7.1K |
| Earning Date | 05-12-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.22 | $0.70 |
| 52 Week High | $2.70 | $5.98 |
Technical Indicators
Market Signals| Indicator | IVDA | BBLG |
|---|---|---|
| Relative Strength Index (RSI) | 63.86 | 52.57 |
| Support Level | $0.23 | $1.30 |
| Resistance Level | $0.38 | $1.36 |
| Average True Range (ATR) | 0.03 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 79.92 | 21.68 |
Price Performance
Historical ComparisonAbout IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About BBLG Bone Biologics Corp
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.